ViBA

Virtual population pharmacokinetic using physiologically based pharmacokinetic model for evaluating bioequivalence of oral lacidipine formulations in dogs.

Yang B, Wu C, Ji B · Asian journal of pharmaceutical sciences · 2017 · Article

10.1016/j.ajps.2016.03.003

Verified evidence

Model scenario comparison

5407d9b5-a8a6-5dc9-8ba9-d6c70198f5b1
Area under the curve (AUC)Pharmacokinetics and drug exposure

Prediction source Version of record · PDF page(s) 2

Study 31ef18e7-3d61-5c06-9203-eb5ad2eecda7 · Prediction record (JSON)

Prediction fields

Endpoint
relative_bioavailability_panel__bioequivalence_interval_threshold_attainment · PDF page(s) 2
Family
pharmacokinetic_exposure · PDF page(s) 2
Measured variable
relative_bioavailability_panel · PDF page(s) 2
Measurement role
exposure_outcome · PDF page(s) 2
Metric
bioequivalence_interval_threshold_attainment · PDF page(s) 2
Model
mechanistic_or_numerical · PDF page(s) 1, 2
Reference type
observed_experimental_reference · PDF page(s) 2
Role
simulated_output · PDF page(s) 2
Scenario
virtual_sample_size_comparison · PDF page(s) 2